Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Largest Real-World Evaluation of Treatment Regimens and Clinical Outcomes Among Patients with Acute Promyelocytic Leukemia in the US: Data from the Command Consortium

Blood (2024) 144 (Supplement 1): 5174.

https://doi.org/10.1182/blood-2024-198914

Published: 2024

Journal Articles

Management and Treatment of Bleeding and Thrombotic Complications of Congenital Afibrinogenemia during Chemotherapy and Bone Marrow Transplant for B-ALL

Kimberley Youkhana, Alexander Coltoff, Tharakeswari Selvakumar, Benjamin Djulbegovic, Charles Greenberg, Shayla Bergmann

Blood (2024) 144 (Supplement 1): 5507.

https://doi.org/10.1182/blood-2024-208793

Published: 2024

Journal Articles

Utility of Early Bone Marrow Responses in FLT3 Mutant Acute Myeloid Leukemia

Vincent Lok, Georgio Medawar, Dahniel L Sastow, Preston Perez, Su Bin Hahn, Abigail Demers, Douglas Tremblay, Alexander Coltoff, David M Swoboda

Blood (2024) 144 (Supplement 1): 5953.

https://doi.org/10.1182/blood-2024-206634

Published: 2024

Journal Articles

Next-Generation Sequencing-Based T-Cell Receptor (TR) Measurable Residual Disease Monitoring Does Not Predict Relapse in T-Lineage Acute Lymphoblastic Leukemia

Rafael Madero-Marroquin, Adnan Askari, Yenny Vanegas Moreno, Clare E Anderson, Talha Badar, Guru Subramanian Guru Murthy, Chenyu Lin, Alexander Coltoff, Adam S. Duvall, Richard A. Larson, Olatoyosi Odenike, Wendy Stock, Anand Ashwin Patel, Caner Saygin

Blood (2024) 144 (Supplement 1): 5937.

https://doi.org/10.1182/blood-2024-203665

Published: 2024

Journal Articles

The Incidence of CNS Relapse in Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) and Its Impact on Clinical Outcome: Results from Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

Blood (2024) 144 (Supplement 1): 4184.

https://doi.org/10.1182/blood-2024-205812

Published: 2024

Journal Articles

Leukemia Physician's Perspective on Transplant in Patients with TP53 Mutated Acute Myeloid Leukemia

Yenny Alejandra Moreno Vanegas, Suhaib Younis Mohamed El Khatib, Brooke Hisrich, Alexander Coltoff, Rory M. Shallis, Anand Ashwin Patel, Jan Philipp Bewersdorf, Timothy S. Oh, Yasmin Abaza, Charles Foucar, Aaron D. Goldberg, Adam S. Duvall, Ehab L. Atallah, Mark R. Litzow, Talha Badar

Blood (2024) 144 (Supplement 1): 1487.

https://doi.org/10.1182/blood-2024-205782

Published: 2024

Journal Articles

Extended Vs Standard Hypomethylating Agent Dosing in Combination with Venetoclax in Newly Diagnosed Acute Myeloid Leukemia

Georgio Medawar, Serena Tharakan, Dahniel L Sastow, Vincent Lok, Su Bin Hahn, Preston Perez, Abigail Demers, David M Swoboda, Douglas Tremblay, Alexander Coltoff

Blood (2024) 144 (Supplement 1): 2904.

https://doi.org/10.1182/blood-2024-209414

Published: 2024

Journal Articles

Clinical Characteristics and Outcomes of Mixed Phenotype Acute Leukemia (MPAL): A Large Multi-Center Retrospective Study

Adam Julian Cohen-Nowak, Alexander Coltoff, Anand Ashwin Patel, Ehab L. Atallah, Mobachir El Kettani, John Wang, Emily Symes, Girish Venkataraman, Alexa Siddon, Emily Giever, Rory M. Shallis, Jessica Kaplan Altman, Kirsten Bell-Burdett, Talha Badar, Barina Aqil, Yasmin Abaza

Blood (2024) 144 (Supplement 1): 2801.

https://doi.org/10.1182/blood-2024-199377

Published: 2024

Journal Articles

Clinical and Molecular Characterization of TP53-Mutant Acute Lymphoblastic Leukemia

Blood (2024) 144 (Supplement 1): 1425.

https://doi.org/10.1182/blood-2024-212213

Published: 2024

Journal Articles

Loss of Heterozygosity of Chromosome 9p and Progression in MPNs

Alexander Coltoff, Kimberly Michelle Green, Praneeth Baratam

Blood (2023) 142 (Supplement 1): 6426.

https://doi.org/10.1182/blood-2023-185061

Published: 2023

Journal Articles

Real World Outcomes of CPX-351 Compared to Traditional Chemotherapy with Cytarabine Consolidation for Treatment of Secondary Acute Myeloid Leukemia

Katelynn Granger, Kelly J Gaffney, Deidra Smith, Erin Weeda, Praneeth Baratam, Kimberly Michelle Green, Alexander Coltoff, James A Davis

Blood (2023) 142 (Supplement 1): 5922.

https://doi.org/10.1182/blood-2023-174231

Published: 2023

Journal Articles

Impact of PTPN11 Mutations in De Novo, Secondary and Relapsed/Refractory Acute Myeloid Leukemia

Alexander Coltoff, Deidra Smith, James A Davis, Kelly J Gaffney, Praneeth Baratam, Kimberly Michelle Green

Blood (2023) 142 (Supplement 1): 5991.

https://doi.org/10.1182/blood-2023-182407

Published: 2023

Journal Articles

Response to COVID-19 Infection and Vaccination in the CLL Population: A Large Single-Center Experience

Alexander Coltoff, Andrew H. Lipsky, Todd L. Rosenblat, Jennifer E. Amengual, Mark L Heaney, Joseph G. Jurcic, Nicole Lamanna

Blood (2022) 140 (Supplement 1): 9893–9895.

https://doi.org/10.1182/blood-2022-167191

Published: 2022

Journal Articles

Graded Renal Response Criteria for Light Chain (AL) Amyloidosis

Blood (2021) 138 (Supplement 1): 2721.

https://doi.org/10.1182/blood-2021-149594

Published: 2021

Journal Articles

Graded Cardiac Response Criteria for AL Amyloidosis: The Impact of Depth of Cardiac Response on Survival

Blood (2021) 138 (Supplement 1): 2720.

https://doi.org/10.1182/blood-2021-149222

Published: 2021

Journal Articles

Minimal Residual Disease Eradication with Venetoclax in Acute Myeloid Leukemia

Alexander Coltoff, MD, Joseph G. Jurcic, MD, Peter Campbell, PharmD, BCOP, Daniel J. Lee, MD, Mark L Heaney, MD, Nicole Lamanna, MD, Todd L. Rosenblat, MD MS, Mark G. Frattini, MDPhD, George Vlad, PhD

Blood (2020) 136 (Supplement 1): 12–14.

https://doi.org/10.1182/blood-2020-134237

Published: 2020

Journal Articles

Prognostic Significance of Hospitalization Status at Second Cycle of Hypomethylating Agent Induction Therapy in Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

Douglas Tremblay, MD, Rafael Madero-Marroquin, MD, Guido Lancman, MD, Alexander Coltoff, MD, Jonathan Feld, MD, Jessica Caro, MD, Nicole Zubizarreta, MPH, Marina Kremyanskaya, Alla Keyzner, MD, Michal Bar-Natan, MD, Shyamala C. Navada, MD, Lewis R. Silverman, Janice L. Gabrilove, MD, John Mascarenhas, MD

Blood (2019) 134 (Supplement_1): 5102.

https://doi.org/10.1182/blood-2019-123288

Published: 2019

Journal Articles

Impact of Primary Antibacterial Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML Patients

Jessica Caro, MD, Erin Moshier, MS, Douglas Tremblay, MD, Alexander Coltoff, MD, Guido Lancman, MD, Meenakshi Rana, MD, John Mascarenhas, MD, Samantha Jacobs, MD

Blood (2019) 134 (Supplement_1): 3849.

https://doi.org/10.1182/blood-2019-123435

Published: 2019

Journal Articles

Outcomes in Multiple Myeloma Patients Progressing on Lenalidomide Maintenance

Larysa Sanchez, MD, Erin Moshier, MS, Alexander Coltoff, MD, Ali Mustafa, MD, Darren Pan, MD BS, Hearn Jay Cho, MD PhD, Sundar Jagannath, MD, Deepu Madduri, MD, Samir Parekh, MD, Shambavi Richard, MD, Joshua Richter, MD, Ajai Chari, MD

Blood (2019) 134 (Supplement_1): 1779.

https://doi.org/10.1182/blood-2019-128441

Published: 2019

Journal Articles

Race, Socioeconomic Status, and Time to Transplantation in Multiple Myeloma

Darren Pan, MD BS, Alexander Coltoff, MD, Umut Ozbek, PhD, Jung-Yi Lin, MS, Solmaz Afshar, BSc, Amir Steinberg, MD

Blood (2018) 132 (Supplement 1): 2263.

https://doi.org/10.1182/blood-2018-99-110316

Published: 2018

NARROW

Largest Real-World Evaluation of Treatment Regimens and Clinical Outcomes Among Patients with Acute Promyelocytic Leukemia in the US: Data from the Command Consortium

Management and Treatment of Bleeding and Thrombotic Complications of Congenital Afibrinogenemia during Chemotherapy and Bone Marrow Transplant for B-ALL

Utility of Early Bone Marrow Responses in FLT3 Mutant Acute Myeloid Leukemia

Next-Generation Sequencing-Based T-Cell Receptor (TR) Measurable Residual Disease Monitoring Does Not Predict Relapse in T-Lineage Acute Lymphoblastic Leukemia

The Incidence of CNS Relapse in Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) and Its Impact on Clinical Outcome: Results from Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

Leukemia Physician's Perspective on Transplant in Patients with TP53 Mutated Acute Myeloid Leukemia

Extended Vs Standard Hypomethylating Agent Dosing in Combination with Venetoclax in Newly Diagnosed Acute Myeloid Leukemia

Clinical Characteristics and Outcomes of Mixed Phenotype Acute Leukemia (MPAL): A Large Multi-Center Retrospective Study

Clinical and Molecular Characterization of TP53-Mutant Acute Lymphoblastic Leukemia

Loss of Heterozygosity of Chromosome 9p and Progression in MPNs

Real World Outcomes of CPX-351 Compared to Traditional Chemotherapy with Cytarabine Consolidation for Treatment of Secondary Acute Myeloid Leukemia

Impact of PTPN11 Mutations in De Novo, Secondary and Relapsed/Refractory Acute Myeloid Leukemia

Response to COVID-19 Infection and Vaccination in the CLL Population: A Large Single-Center Experience

Graded Renal Response Criteria for Light Chain (AL) Amyloidosis

Graded Cardiac Response Criteria for AL Amyloidosis: The Impact of Depth of Cardiac Response on Survival

Minimal Residual Disease Eradication with Venetoclax in Acute Myeloid Leukemia

Prognostic Significance of Hospitalization Status at Second Cycle of Hypomethylating Agent Induction Therapy in Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

Impact of Primary Antibacterial Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML Patients

Outcomes in Multiple Myeloma Patients Progressing on Lenalidomide Maintenance

Race, Socioeconomic Status, and Time to Transplantation in Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only